S๐ญ๐ซ๐๐ง๐ ๐ญ๐ก๐๐ง๐ข๐ง๐ ๐ญ๐ก๐ ๐๐ก๐๐ซ๐ฆ๐๐๐ฒ ๐๐ซ๐จ๐๐๐ฌ๐ฌ๐ข๐จ๐ง ๐ข๐ง ๐๐๐ง๐ฒ๐: ๐ ๐๐๐ฅ๐ฅ ๐๐จ๐ซ ๐๐จ๐ฅ๐ฅ๐๐๐จ๐ซ๐๐ญ๐ข๐จ๐ง
Mombasa, KENYA โ During the 19th Annual Pharmaceutical Conference, the Chief Executive Officer (CEO) of the Pharmacy and Poisons Board (PPB) highlighted the urgent need for collaboration to fortify the pharmacy profession in Kenya.
The conference, hosted by the Kenya Pharmaceutical Association, provided a platform for professionals and stakeholders committed to advancing the field.
The CEO, Dr. F. M. Siyoi whose speech was read by Dr. Dominic Mutie, Deputy Director of Pharmacy Practice and Training, began by reaffirming the PPBโs dedication to creating a conducive environment for pharmacy practice and regulation. Emphasizing the importance of a robust regulatory framework, the CEO underscored the need to ensure the safety, efficacy, and quality of pharmaceutical products reaching the citizens.
Addressing a significant challenge, the CEO urged all stakeholders to unite in eliminating unqualified individuals and quacks from the pharmaceutical field. Proposing โnyumba kumiโ initiatives within communities, the call aimed to identify and remove such individuals, safeguarding the professionโs integrity and protecting the public from potential harm.
Aligned with the PPBโs mission to achieve WHO Level 3 maturity, the CEO emphasized the necessity of staying updated and compliant with guidelines. Delegates were encouraged to engage with the PPBโs new guidelines, particularly those concerning good distribution practices, transportation of pharmaceutical products, and proper pharmaceutical waste disposal.
Furthermore, the CEO called for a close partnership between the Kenya Pharmaceutical Association and the Pharmacy and Poisons Board at both national and regional levels. Such collaboration, he noted, would streamline efforts and efficiently address challenges facing the profession, creating a stronger, unified voice.
Adherence to pharmacy practice guidelines, especially concerning prescription medicines and controlled substances, was underscored as essential in maintaining public trust in healthcare providers. The delegates were reminded of the critical role designated superintendents play in ensuring the quality of services provided.
The conference also addressed critical issues affecting the profession, including the elevation of pharmaceutical services at level 4 hospitals and the upgrading of career conversion programs for pharmaceutical technologists. Additionally, the PPB is actively developing comprehensive Standards of Pharmacy Practice to promote professionalism across all sectors.